Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Oncocyte to Release First Quarter 2025 Results on May 12, 2025
-
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
-
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
-
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
-
Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
-
Oncocyte Prices $29.1 Million Equity Offering
-
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
-
Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
-
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings – January 13-16, 2025, San Francisco, CA
-
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study